Human Phototoxicity Test
NCT02751541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2018-12-13
Summary
To determine the phototoxic potential of a topically applied article in human subjects.
Conditions
- Sunscreening Agents
Interventions
- DRUG
-
Sunscreen Sport Spray (BAY987519)
50 μl/cm\*2 or 0.05 gm/cm\*2 of each test product is applied to duplicate skin sites (approximately 2 x 2 cm each). After the test articles have dried for 5 to 15 min, the sites are covered by the appropriate patch.24 hours later, the set of patches covering the product are removed. Three (3) μl/ cm2 or 0.003 gm/cm\*2 of the test product is reapplied to the test site, air dried for 5 to 15 minutes for volatilization and then the test site is exposed to UVA radiation.(Formulation number - RB#Y51-002)
- OTHER
-
Untreated Skin
This site is patched without treatment as irradiated control.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-02
- Primary Completion
- 2016-05-06
- Completion
- 2016-05-06
Countries
- United States
Study Locations
More Related Trials
-
Test the Outdoor Usage for Sunscreen Products in Female Adults
NCT02779270 ·Status: COMPLETED ·Phase: NA
-
Dermal Phototoxicity Study
NCT04070742 ·Status: COMPLETED ·Phase: PHASE1
-
Study of NST-6179 in Healthy Subjects
NCT05181085 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers
NCT03102489 ·Status: COMPLETED ·Phase: PHASE1
-
Phototoxicity of Frequently Prescribed Medicines
NCT06710600 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial
NCT05277376 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers
NCT03926819 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet
NCT03804671 ·Status: COMPLETED ·Phase: PHASE1
-
Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)
NCT00983255 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects
NCT02434835 ·Status: COMPLETED ·Phase: PHASE1
-
A PK and Safety Study in Subjects With Hepatic Impairment
NCT01431833 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
NCT03603106 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)
NCT01679587 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD
NCT06488313 ·Status: RECRUITING ·Phase: PHASE2
-
A Study in Healthy Men to Test How BI 1291583 is Processed in the Body
NCT05833035 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight
NCT04364464 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function
NCT02170571 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX
NCT01367483 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults
NCT02478281 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)
NCT01933503 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
NCT01761526 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacologic Profile of Sodium Thiosulfate in Renal Failure and Healthy Volunteers
NCT01008631 ·Status: COMPLETED ·Phase: NA
-
Human Study of Hydroxytyrosol on Phase II Enzymes in Healthy Subjects
NCT02273622 ·Status: COMPLETED ·Phase: NA
-
A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia
NCT04836494 ·Status: TERMINATED ·Phase: PHASE1
-
Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire
NCT03080298 ·Status: COMPLETED ·Phase: PHASE2